CardioLogical Solutions Receives Two Additional Patents for Its Aortic Embolic Protection Devices Designed to Prevent Stroke and Other Ischemic Complications

Published: Sep 26, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ALTOS, Calif.--(BUSINESS WIRE)--CardioLogical Solutions, an emerging cardiovascular device company, announced today that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications. The new patents include its first issued patent for its groundbreaking Emboline CAP™ technology, the only aortic embolic protection solution to offer comprehensive arterial protection, as well as a further patent for its broad embolic deflector intellectual property portfolio. CardioLogical Solutions now has four issued patents for aortic embolic protection—the most comprehensive intellectual property portfolio in this critical field.

Help employers find you! Check out all the jobs and post your resume.

Back to news